Form 4: Zoetis Inc. Executive Vice President Roxanne Lagano Reports Sale of Common Stock

Executive Vice President Roxanne Lagano sold 923 shares of Zoetis Inc. common stock at $151.17 per share on April 18, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Summary

• On April 18, 2024, Roxanne Lagano, an Executive Vice President at Zoetis Inc., sold 923 shares of common stock at a price of $151.17 per share.
• The sale was executed under a Rule 10b5-1 trading plan adopted on June 1, 2023.
• Following the transaction, Lagano directly owns 14,800 shares of Zoetis Inc. common stock.
• Lagano also indirectly owns 802.2734 shares through the Zoetis Inc. Savings Plan, a 401(k) plan, as of March 31, 2024.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing reporting a routine stock sale by an executive under a pre-arranged trading plan. It doesn't contain information that would significantly impact investor sentiment positively or negatively.

Industry Context

This is a routine disclosure of insider trading activity. It is common for executives to sell shares under pre-arranged trading plans to avoid accusations of trading on inside information.

Comparison to Industry Standards

• Executive stock sales are a common occurrence in publicly traded companies like Zoetis.
• Comparable companies such as Elanco Animal Health and Merck Animal Health also see similar insider trading activity reported via Form 4 filings.
• The use of Rule 10b5-1 trading plans is a standard practice to ensure compliance with insider trading regulations.

Stakeholder Impact

• The stock sale has a minimal impact on shareholders as it is a small transaction by an individual executive.
• There is no direct impact on employees, customers, suppliers, or creditors.

Key Dates